3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
10
Filgrastim
7
Ifosfamide
4
Carboplatin
4
aldesleukin
3
Temozolomide
3
Peripheral Blood Stem Cell Transplantation
3
Drug Therapy
3
Docetaxel
3
Cyclophosphamide
3
Counseling
3
fludarabine phosphate
2
fludarabine
2
etoposide phosphate
2
cemiplimab
2
belinostat
2
atezolizumab
2
Thiotepa
2
Surveys and Questionnaires
2
Radiotherapy
2
Nivolumab
2
Methods
2
Metformin
2
Early Intervention, Educational
2
Doxorubicin
2
Bupropion
2
Blood Specimen Collection
2
Amifostine
2
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
2
valspodar
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Referral and Consultation
×
Gynecologic
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts